Global Breast Implant Market Share, Industry Growth and Report 2023-2028

Comments · 191 Views

The global breast implant market size reached US$ 2.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028.

IMARC Group, a leading market research company, has recently releases report titled “Breast Implant Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global breast implant market share, size, growth, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

A breast implant is an advanced medical prosthesis used to enhance and reconstruct the physical appearance of a breast. It is commonly made of silicone or saline and is surgically inserted behind the breast tissue or beneath the chest muscle to achieve the desired size. It is available in various shapes, such as round, anatomical, smooth, and textured. It is durable and designed to be biocompatible to minimize the risk of tissue rejection. It helps in correcting asymmetrical breasts and improving self-confidence and body image. It is widely used in post-mastectomy and after other surgeries that alter the natural shape of the breast. It is also utilized in some male-to-female transgender hormone replacement therapies.

The global breast implant market size reached US$ 2.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028. 

Request Sample Copy of This Report: https://www.imarcgroup.com/breast-implant-market/requestsample

What are the growth prospects and trends in the breast implant industry?

The rising popularity of cosmetic surgeries worldwide, especially breast augmentation, represents one of the key factors positively influencing the market. Additionally, the inflating disposable income of individuals is allowing them to invest in elective surgeries.

Apart from this, the growing social acceptance and legalization of transgender rights is resulting in increasing gender confirmation surgeries, which is offering a favorable market outlook. Furthermore, technological improvements in implant materials and surgical techniques are enhancing the safety and efficacy of breast implants.

Moreover, continuous advancements in post-mastectomy breast reconstruction techniques are strengthening the growth of the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

  • Silicone Breast Implants
  • Saline Breast Implants

Breakup by Shape:

  • Round
  • Anatomical

Breakup by Application:

  • Cosmetic Surgery
  • Reconstructive Surgery

Breakup by End User:

  • Hospitals
  • Cosmetology Clinics
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Allergen Plc
  • CEREPLAS
  • Establishment Labs SA
  • Global Consolidates Aesthetics Limited
  • Groupe Sebbin SAS
  • HansBiomed Co. Ltd.
  • Ideal Implant Inc.
  • Laboratories Arion
  • Mentor Worldwide LLC (Johnson & Johnson)
  • POLYTECH Health & Aesthetics GmbH
  • Sientra Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Comments